The atherosclerotic plaque

Puerto Rico Health Sciences Journal

Volumn 27, Issue 3, 2008, Pages 241-246

  Mundo Sagardia J A ^a   Figueroa, Y ^a   Altieri, P I ^a,b   Banchs, H L ^a   Escobales, N ^a   Crespo, M J ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b NONE   (Puerto Rico)

Author keywords

Atherosclerosis; Colla?gen; Endothelium; Inflammation; Lipids; Macrophages; Matrix metalloproteinases; Smooth muscle cell; Statins; Thrombosis; Vulnerable plaque; Wall stress

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; HUMAN;

ATHEROSCLEROSIS; HUMANS;

EID: 58149112824     PISSN: 07380658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Korsholm T, Pasterkamp G, Falk E. Plaque instability and remodeling: mechanisms and possible misconceptions. In: Fuster V, Insull W, eds. Assessing and modifying the vulnerable atherosclerotic plaque. 1 ed. Armonk: Futura Publishing Company; 2002. p. 225-226.
2. Libby P. The vascular biology of atherosclerosis. In: Braunwald E, Zipes DP, Libby P, eds. Heart Disease: a textbook of cardiovascular medicine. 6 th ed. Philadelphia: W.B. Saunders Company 2001. p. 996-1002.
3. Dalager-Pedersen S, Morre E. Ringgaard S, Falk E. Coronary artery disease: plaque vulnerability, disruption and thrombosis. In: Fuster V, Cornhill J, eds. The vulnerable atherosclerotic plaque: understanding, identification and modification. 1 ed. Armonk: Futura Publishing Company; 1999. p. 1-5.
4. Davies MJ, Richardson PD, Woolf N, et al. Risk of thrombosis in human atherosclerotic plaques: Role of extracellular lipid, macrophage and smooth muscle cell content. Br Heart J 1993;69:377-381.
5. Burleigh MC, Briggs AD, Lendon CL, et al. Collagen types I and III, collagen content, GAGs and mechanical strength of human atherosclerotic plaque caps: Span-wise variations. Atherosclerosis 1992; 96:71-81.
6. Moreno PR, Falk E, Palacios IF, et al. Macrophages infiltration in acute coronary syndromes: Implications for plaque rupture. Circu?lation 1994;90:775-778.
7. Kloner RA, Giacomelli F, Alker KJ, et al. Influx of neutrophils into the walls of large epicardial arteries in response to ischemia/reperfusion. Circulation 1991;84:1758-1772.
8. Libby P, Schonbeck U. CD40 signaling and plaque instability. Circulation Res 2001;89:1092-1103.
9. Kerwin W, Hooker A, Spilker M, Vicini P, Ferguson M, Hatsukami T, et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 2003;107:851-856.
10. Lee RT, Kamm RD. Vascular mechanics for the cardiologist. J Am Coll Cardiol 1994;23:1289-1295.
11. Loree HM, Kamm RD, Stringfellow RG, Lee RT. Effects of fibrous cap thickness on peak circumferential stress in model atherosclerotic vessels. Cir Res 1992;71:850-858.
12. MacIsaac AI, Thomas JD, Topol EJ. Toward the quiescent coronary plaque. J Am Coll Cardiol 1993;22:1228-1241.
13. Bogaty P, Hackett D, Davies G, Maseri A. Vasoreactivity of the culprit lesion in unstable angina. Circulation 1994;90:5-11.
14. Bertrand ME, La Blanche JM, Tilmant PY, et al. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 1982;65:1299-1306.
15. Barger AC, Beeuwkees R. Rupture of coronary vaso vasorum as a trigger of acute myocardial infarction. Am J Cardiol 1990;66(Suppl G):41G-43G.
16. Gertz SD, Roberts WC. Hemodynamics shear forces in rupture of coronary arterial atherosclerotic plaques. Am J Cardiol 1990;66:1368-1372.
17. Virmani R, Kolodgie FD, Burke AP, et al. Lesson from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275.
18. Maseri A, Fuster V. Is there a vulnerable plaque? Circulation 2003;107:2068-2071.
19. Castrillo A, Tontonoz P. PPARs in atherosclerosis: the clot thickens. J Clin Invest 2004;114:1538-1540.
20. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998;391:79-82.
21. Li AC, et al. Peroxisome proliferator activated-receptor γ ligands inhibit development of atherosclerosis in LDL receptor deficient mice. J Clin Invest 2000;106:523-531.
22. Li AC, et al. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα,β/δ and γ. J Clin Invest 2004;114:1564-1576.
23. Takemoto M, Liao J. Pleiotropic effects of 3-hdroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler Thromb Vasc Biol 2001;21:1712-1719.
24. Escobales N, Crespo M, Altieri PI, Furilla RA. Inhibition of smooth muscle cell calcium mobilization and aortic ring contraction by lactone vastatins. J Hypertens 1996;14:115-121.
25. Fitzgerald JD. By what means might beta blockers prolong life after acute myocardial infarction? Eur Heart J 1987;8:945-951.
26. Jeanpierre E, Le Tourneau T, Six I, Zawadzki C, Van Belle Ezekowitz M, et al. Dietary lipid lowering modifies plaque phenotype in rabbit atheroma after angio-plasty. Circulation 2003;108:1740-1745.
27. Helft G, Worthley S, Fuster V, Fayad Z, Zaman A, Corti R, et al. Progression and regression of atherosclerotic lesions monitoring with serial noninvasive magnetic resonance imaging.Circulation 2002;105:993-998.